| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |